Company Overview and News

 
Tata Motors Limited - Financial Results Updates

5h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Tata Motors Limited - Financial Results Updates

5h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
Ashok Leyland plans to redesign LCVs to target e-commerce industry

19h livemint
Mumbai: The Hinduja Group flagship, Chennai-based Ashok Leyland, plans to redesign its light commercial vehicles (LCVs) to serve the fast-growing Indian e-commerce industry’s last-mile delivery needs, according to a senior company executive.

 
Moneycontrol Research tweaks its defensive portfolio, replaces Tata Motors with Bharat Dynamics

2018-04-18 moneycontrol
As a part of our constant endeavour to remain ahead of the curve when it comes to identifying investment opportunities, we at Moneycontrol are tweaking our portfolio of defensive stocks to include recently-listed Bharat Dynamics in place of Tata Motors.

 
Ashok Leyland lines up Rs 1000 crore capex this year, to launch 30 new products

2018-04-18 moneycontrol
Ashok Leyland, the country’s third biggest truck and bus maker, will spend Rs 1000 crore as capital expenditure, launch 30 products to further improve its performance, a top company executive said.

 
Sensex rises over 100 points, Nifty nears 10,600

2018-04-18 freepressjournal.in
Mumbai: The BSE Sensex rose over 100 points in early trade today, continuing its winning spree for the 10th straight session, on positive global leads and sustained buying by domestic institutional investors. The 30-share index moved higher by 110.13 points, or 0.32 per cent, to 34,505.19. The gauge had gained 1,375.99 points in the previous nine sessions.

 
M&M joins ₹1-trillion m-cap club

2018-04-17 thehindubusinessline
Our Bureau For the shares of Mahindra & Mahindra, it was a dream day as they entered the prestigious ₹1 lakh crore market capitalisation club after the stock settled with gains of over 1 per cent.

 
Driverless Cars Look Past Accidents as Ford (F) Joins Race

2018-04-17 zacks
The last month saw two accidents involving self-driving cars but that hasn’t dented the spirit of automakers. Autonomous cars continue to be a major area of focus for most automakers and Ford Motor Company (F - Free Report) is the latest to jump the bandwagon. Ford, reportedly, plans to launch its own self-driving car fleet by 2021 to transport and deliver goods. Although Ford is a late entrant in the self-driving car space, it is now quite evident that every major automaker is thinking along those lines with autonomous cars becoming top priority to stay in the race.

 
Sensex, Nifty clock gains for 9th consecutive session; investors await corporate earnings

2018-04-17 moneycontrol
Bulls continued to have upper hand at Dalal Street for the ninth consecutive session on Tuesday after normal monsoon forecast for June-September period, as investors await corporate earnings. Positive global cues also boosted sentiment.

 
Closing Bell: Sensex ends rangebound session higher; hotels, jewellery, realty stocks rally

2018-04-17 moneycontrol
3:30 pm Market Closing: Benchmark indices managed to end near day's high after volatility throughout the session.

 
Market Live: Nifty holds 10,500 amid consolidation; corporate earnings eyed

2018-04-17 moneycontrol
1:58 pm Car Price Hike: Toyota Kirloskar Motor (TKM) is planning to increase vehicle prices from next month in order to partially offset rise in input costs.

 
Market Update: TCS, Wipro shed 1% as CNX IT drags; Power Grid top gainer, Bharti Infratel down 2%

2018-04-17 moneycontrol
The Indian equity market slipped into the red on Tuesday afternoon with the Nifty shedding 23 points and was trading just above the 10,500 mark at 10,505 while the Sensex was down 44 points or 0.13 percent.

 
Market Live: Sensex, Nifty trade lower; all sectoral indices in red except FMCG

2018-04-17 moneycontrol
12:42 pm Market Update: The market is trading mildly lower amid consolidation, after rising in previous 8 consecutive sessions, as investors look for more corporate earnings due over next one and half months.

 
Market Live: Sensex, Nifty mildly higher amid consolidation; metals, PSU banks shine

2018-04-17 moneycontrol
11:01 am Market Check: Benchmark indices traded with mild gains amid consolidation as investors after digesting normal monsoon forecast look for more corporate earnings.

 
Sensex extends gains on normal monsoon forecast

2018-04-17 freepressjournal.in
Mumbai: Extending its rising streak for the ninth session, the benchmark BSE Sensex advanced nearly 100 points in opening trade today, after forecast of a normal monsoon for the year.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...